School of Infection & Immunity

Dr Gareth Jones

  • Clinical Senior Research Fellow (Immunology & Infection)

Biography

Gareth trained in Medicine in Aberdeen before undertaking core medical training in Glasgow, where his gastroenterology research career started with Professor Ken McColl.

He then worked in Edinburgh IBD unit for 15 years, including a Wellcome Trust funded PhD under the Edinburgh Clinical Academic Training (ECAT) scheme with Professor Andrew MacDonald and Professor Adrian Bird, investigating the role of DNA-methyl binding proteins in murine models of colitis, based at Manchester Centre for Collaborative Inflammation Research (MCCIR).

Next, Gareth performed post-doctoral research with Professor Charlie Lees, leading the development of The Lothian IBD registry before being awarded a European Crohn’s Colitis Organisation (ECCO) Science Award and Wellcome Trust Clinical Research Career Development Fellowship in 2018/19 to investigate macrophage heterogeneity in Crohn’s disease.

He is now a new group leader in human gut immunology, focusing on the dual role of myeloid cells as instigators of both barrier damage and barrier repair in IBD, and also the clinician forum representative to the British Society for Immunology, working closely with international collaborators, including Carl Anderson (Sanger Institute), Bill Agace (University of Copenhagen) and James Lee (The Francis Crick Institute) to further understanding of the biology of IBD.

Publications

List by: Type | Date

Jump to: 2026 | 2021 | 2020 | 2019 | 2018 | 2015 | 2014 | 2012 | 2011
Number of items: 12.

2026

Matellan, C. et al. (2026) TWEAK is increased in ulcerative colitis and contributes to fibroblast-mediated monocyte activation via heterologous non-canonical NF-kB/STAT3 signaling. Journal of Crohn's and Colitis, 20(2), jjag012. (doi: 10.1093/ecco-jcc/jjag012) (PMID:41765035)

Hegarty, Lizi M., Jones, Gareth-Rhys ORCID logoORCID: https://orcid.org/0000-0001-7355-2357, Biram, Adi, Adams, Claire E., Gentek, Rebecca M., Ho, Gwo-Tzer, Emmerson, Elaine and Bain, Calum ORCID logoORCID: https://orcid.org/0000-0001-8884-327X (2026) Tissue resident colonic macrophages persist through acute inflammation and adapt to aid tissue repair. Mucosal Immunology, 19(1), pp. 1624-1635. (doi: 10.1016/j.mucimm.2025.11.007) (PMID:41248849)

2021

McCowan, J. et al. (2021) The transcription factor EGR2 is indispensable for tissue-specific imprinting of alveolar macrophages in health and tissue repair. Science Immunology, 6(65), eabj2132. (doi: 10.1126/sciimmunol.abj2132) (PMID:34797692) (PMCID:PMC7612216)

2020

Kennedy, N. A. et al. (2020) British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut, 69(6), pp. 984-990. (doi: 10.1136/gutjnl-2020-321244) (PMID:32303607) (PMCID:PMC7211081)

2019

Plevris, N. et al. (2019) Real-world effectiveness and safety of Vedolizumab for the treatment of inflammatory bowel disease: The Scottish Vedolizumab Cohort. Journal of Crohn's and Colitis, 13(9), pp. 1111-1120. (doi: 10.1093/ecco-jcc/jjz042) (PMID:30768123)

2018

Jones, Gareth-Rhys ORCID logoORCID: https://orcid.org/0000-0001-7355-2357, Bain, Calum C., Fenton, Thomas M., Kelly, Aoife, Brown, Sheila L., Ivens, Alasdair C., Travis, Mark A., Cook, Peter C. and MacDonald, Andrew S. (2018) Dynamics of colon monocyte and macrophage activation during colitis. Frontiers in Immunology, 9, 2764. (doi: 10.3389/fimmu.2018.02764) (PMID:30542349) (PMCID:PMC6277765)

May, S. et al. (2018) Mbd2 enables tumourigenesis within the intestine while preventing tumour-promoting inflammation. Journal of Pathology, 245(3), pp. 270-282. (doi: 10.1002/path.5074) (PMID:29603746) (PMCID:PMC6032908)

2015

Cook, P. C. et al. (2015) A dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells. Nature Communications, 6, 6920. (doi: 10.1038/ncomms7920) (PMID:25908537) (PMCID:PMC4413429)

2014

Heap, G. A. et al. (2014) HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nature Genetics, 46(10), pp. 1131-1134. (doi: 10.1038/ng.3093) (PMID:25217962)

Jones, G.R. ORCID logoORCID: https://orcid.org/0000-0001-7355-2357, Kennedy, N. A., Lees, C. W., Arnott, I. D. and Satsangi, J. (2014) Systematic review: the use of thiopurines or anti‐ TNF in post‐operative Crohn's disease maintenance – progress and prospects. Alimentary Pharmacology and Therapeutics, 39(11), pp. 1253-1265. (doi: 10.1111/apt.12743)

2012

Derakhshan, M.H., Robertson, E.V., Fletcher, J., Jones, G.-R. ORCID logoORCID: https://orcid.org/0000-0001-7355-2357, Lee, Y.Y., Wirz, A.A. and McColl, K.E.L. (2012) Mechanism of association between BMI and dysfunction of the gastro-oesophageal barrier in patients with normal endoscopy. Gut, 61(3), pp. 337-343. (doi: 10.1136/gutjnl-2011-300633) (PMID:21873737)

2011

Fletcher, J., Derakhshan, M.H., Jones, G.-R. ORCID logoORCID: https://orcid.org/0000-0001-7355-2357, Wirz, A.A. and McColl, K.E.L. (2011) BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy. Gut, 60(4), pp. 442-448. (doi: 10.1136/gut.2010.228064) (PMID:21159892)

This list was generated on Sun Nov 15 22:27:16 2026 GMT.
Jump to: Articles
Number of items: 12.

Articles

Matellan, C. et al. (2026) TWEAK is increased in ulcerative colitis and contributes to fibroblast-mediated monocyte activation via heterologous non-canonical NF-kB/STAT3 signaling. Journal of Crohn's and Colitis, 20(2), jjag012. (doi: 10.1093/ecco-jcc/jjag012) (PMID:41765035)

Hegarty, Lizi M., Jones, Gareth-Rhys ORCID logoORCID: https://orcid.org/0000-0001-7355-2357, Biram, Adi, Adams, Claire E., Gentek, Rebecca M., Ho, Gwo-Tzer, Emmerson, Elaine and Bain, Calum ORCID logoORCID: https://orcid.org/0000-0001-8884-327X (2026) Tissue resident colonic macrophages persist through acute inflammation and adapt to aid tissue repair. Mucosal Immunology, 19(1), pp. 1624-1635. (doi: 10.1016/j.mucimm.2025.11.007) (PMID:41248849)

McCowan, J. et al. (2021) The transcription factor EGR2 is indispensable for tissue-specific imprinting of alveolar macrophages in health and tissue repair. Science Immunology, 6(65), eabj2132. (doi: 10.1126/sciimmunol.abj2132) (PMID:34797692) (PMCID:PMC7612216)

Kennedy, N. A. et al. (2020) British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut, 69(6), pp. 984-990. (doi: 10.1136/gutjnl-2020-321244) (PMID:32303607) (PMCID:PMC7211081)

Plevris, N. et al. (2019) Real-world effectiveness and safety of Vedolizumab for the treatment of inflammatory bowel disease: The Scottish Vedolizumab Cohort. Journal of Crohn's and Colitis, 13(9), pp. 1111-1120. (doi: 10.1093/ecco-jcc/jjz042) (PMID:30768123)

Jones, Gareth-Rhys ORCID logoORCID: https://orcid.org/0000-0001-7355-2357, Bain, Calum C., Fenton, Thomas M., Kelly, Aoife, Brown, Sheila L., Ivens, Alasdair C., Travis, Mark A., Cook, Peter C. and MacDonald, Andrew S. (2018) Dynamics of colon monocyte and macrophage activation during colitis. Frontiers in Immunology, 9, 2764. (doi: 10.3389/fimmu.2018.02764) (PMID:30542349) (PMCID:PMC6277765)

May, S. et al. (2018) Mbd2 enables tumourigenesis within the intestine while preventing tumour-promoting inflammation. Journal of Pathology, 245(3), pp. 270-282. (doi: 10.1002/path.5074) (PMID:29603746) (PMCID:PMC6032908)

Cook, P. C. et al. (2015) A dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells. Nature Communications, 6, 6920. (doi: 10.1038/ncomms7920) (PMID:25908537) (PMCID:PMC4413429)

Heap, G. A. et al. (2014) HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nature Genetics, 46(10), pp. 1131-1134. (doi: 10.1038/ng.3093) (PMID:25217962)

Jones, G.R. ORCID logoORCID: https://orcid.org/0000-0001-7355-2357, Kennedy, N. A., Lees, C. W., Arnott, I. D. and Satsangi, J. (2014) Systematic review: the use of thiopurines or anti‐ TNF in post‐operative Crohn's disease maintenance – progress and prospects. Alimentary Pharmacology and Therapeutics, 39(11), pp. 1253-1265. (doi: 10.1111/apt.12743)

Derakhshan, M.H., Robertson, E.V., Fletcher, J., Jones, G.-R. ORCID logoORCID: https://orcid.org/0000-0001-7355-2357, Lee, Y.Y., Wirz, A.A. and McColl, K.E.L. (2012) Mechanism of association between BMI and dysfunction of the gastro-oesophageal barrier in patients with normal endoscopy. Gut, 61(3), pp. 337-343. (doi: 10.1136/gutjnl-2011-300633) (PMID:21873737)

Fletcher, J., Derakhshan, M.H., Jones, G.-R. ORCID logoORCID: https://orcid.org/0000-0001-7355-2357, Wirz, A.A. and McColl, K.E.L. (2011) BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy. Gut, 60(4), pp. 442-448. (doi: 10.1136/gut.2010.228064) (PMID:21159892)

This list was generated on Sun Nov 15 22:27:16 2026 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Determining the role of monocyte activin on the intestinal epithelium
    The Royal Society
    2025 - 2026
     
  • Decoding macrophage functional heterogeneity in the pathogenesis of Crohn's disease
    Wellcome Trust
    2025 - 2026